CING Logo

Cingulate Inc. (CING) 

NASDAQ$3.96
Market Cap
$12.72M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
520 of 922
Rank in Industry
304 of 526

CING Insider Trading Activity

CING Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$8411100

Related Transactions

Myers LaurieEVP and COO0$01$841$-841

About Cingulate Inc.

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

Insider Activity of Cingulate Inc.

Over the last 12 months, insiders at Cingulate Inc. have bought $0 and sold $841 worth of Cingulate Inc. stock.

On average, over the past 5 years, insiders at Cingulate Inc. have bought $458,420 and sold $11,525 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,000 shares for transaction amount of $3,349 was made by Callahan Jennifer L. (Corporate Controller) on 2023‑09‑15.

List of Insider Buy and Sell Transactions, Cingulate Inc.

2024-08-15SaleMyers LaurieEVP and COO
202
0.0346%
$4.17$841-5.83%
2023-09-15PurchaseCallahan Jennifer L.Corporate Controller
5,000
0.031%
$0.67$3,349-91.95%
2023-08-11PurchaseWerth Peter J.director
1.82M
16.1208%
$0.55$1M-88.68%
2023-05-15PurchaseCallahan Jennifer L.Corporate Controller
2,000
0.0184%
$1.01$2,020-61.39%
2023-05-12PurchaseCallahan Jennifer L.Corporate Controller
4,000
0.0374%
$1.08$4,320-62.62%
2022-12-16PurchaseSchaffer Shane J.Chief Executive Officer
10,000
0.0879%
$1.02$10,166-11.54%
2022-12-14PurchaseCallahan Jennifer L.Corporate Controller
7,548
0.0728%
$0.99$7,468+0.16%
2022-12-14PurchaseSchaffer Shane J.Chief Executive Officer
13,267
0.1305%
$1.01$13,400+0.16%
2022-12-13PurchaseWerth Peter J.director
28,934
0.2505%
$0.98$28,422-9.36%
2022-12-13PurchaseSchaffer Shane J.Chief Executive Officer
1,733
0.0154%
$1.01$1,750-9.36%
2022-11-29PurchaseCallahan Jennifer L.Corporate Controller
1,530
0.0144%
$0.98$1,499+0.64%
2022-11-28PurchaseCallahan Jennifer L.Corporate Controller
3,487
0.0304%
$0.98$3,417-7.00%
2022-11-23PurchaseMyers LaurieEVP and COO
1,111
0.0098%
$0.90$1,000+2.74%
2022-11-23PurchaseGilgallon Craig S.EVP, GC and Secretary
3,575
0.0295%
$0.84$3,003+2.74%
2022-11-22PurchaseGIVENS GREGG WMdirector
85,000
0.766%
$0.88$74,851+6.90%
2022-09-08PurchaseCallahan Jennifer L.Corporate Controller
3,500
0.0312%
$1.50$5,250-33.89%
2022-09-06PurchaseWerth Peter J.
74,500
0.6459%
$1.52$113,225-36.13%
2022-09-01PurchaseMyers LaurieEVP and COO
636
0.0057%
$1.57$999-36.13%
2022-06-01PurchaseMyers LaurieEVP and COO
200
0.0018%
$1.18$236-6.90%
2022-05-17PurchaseMyers LaurieEVP and COO
200
0.0017%
$1.21$242-12.19%
Total: 27
*Gray background shows transactions not older than one year

CING Institutional Investors: Active Positions

Increased Positions6+46.15%64,535+129.05%
Decreased Positions6-46.15%23,827-47.65%
New Positions3New27,711New
Sold Out Positions4Sold Out21,466Sold Out
Total Postitions13company.total90,714+81.41%

CING Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Commonwealth Equity Services, Llc$154.001.43%43,022+31,746+281.54%2024-12-31
Geode Capital Management, Llc$98.000.91%27,323+27,323New2024-12-31
Ubs Group Ag$44.000.41%12,196-1,553-11.29%2024-12-31
Alphamark Advisors, Llc$18.000.17%5,010+5,000+50,000%2024-12-31
Bank Of America Corp /De/$7.000.07%1,956+78+4.15%2024-12-31
Tower Research Capital Llc (Trc)$3.000.03%764-808-51.4%2024-12-31
Citigroup Inc$1.000.01%387+387New2024-12-31
Osaic Holdings, Inc.$0<0.01%5500%2024-12-31
Sbi Securities Co., Ltd.$00%1+<1New2024-12-31
Fmr Llc$00%0-352Sold Out2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.